Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Therapeutic Eradication of Cancer Stem Cells with UC-961 (Cirmtuzumab)

  • Post author:
  • Post published:July 13, 2025
  • Post category:

Cancer is a leading cause of death in California. Research has found that many cancers can spread throughout the body and resist current anti-cancer therapies because of cancer stem cells,…

Continue ReadingTherapeutic Eradication of Cancer Stem Cells with UC-961 (Cirmtuzumab)

Clinical Development of an N-cadherin Antibody to Target Cancer Stem Cells

  • Post author:
  • Post published:July 13, 2025
  • Post category:

Metastatic disease and the castration resistance remain tremendous challenges in the treatment of prostate cancer. New targeted treatments, such as the ant-testosterone medication enzalutamide, have improved the survival of men…

Continue ReadingClinical Development of an N-cadherin Antibody to Target Cancer Stem Cells

Trop2 dependent and independent mechanisms of self-renewal in human cancer stem cells

  • Post author:
  • Post published:July 13, 2025
  • Post category:

Progress from our group and others has led to the identification of normal prostate tissue stem cells and the definition of important signaling pathways that regulate their growth and maintenance.…

Continue ReadingTrop2 dependent and independent mechanisms of self-renewal in human cancer stem cells

Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells

  • Post author:
  • Post published:July 13, 2025
  • Post category:

Leukemias are cancers of the blood cells that result from corruption of the normal controls that regulate blood-forming stem cells. They are serious causes of illness and death, and are…

Continue ReadingProstaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells

Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

  • Post author:
  • Post published:July 13, 2025
  • Post category:

Leukemia is the most frequent form of cancer in children and teenagers, but is also common in adults. Chemotherapy has vastly improved the outcome of leukemia over the past four…

Continue ReadingDual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

  • Post author:
  • Post published:July 13, 2025
  • Post category:

Leukemia is the most frequent form of cancer in children and teenagers, but is also common in adults. Chemotherapy has vastly improved the outcome of leukemia over the past four…

Continue ReadingDual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy

  • Post author:
  • Post published:July 13, 2025
  • Post category:

Cancer is the leading cause of death for individuals under 85. Relapse and metastatic disease are the leading causes of cancer related mortality. Anti-apoptotic BCL2 family member overexpression has been…

Continue ReadingPreclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy

Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells

  • Post author:
  • Post published:July 13, 2025
  • Post category:

Various cells and organs in the human body originate from a small group of primitive cells called stem cells. Human cancer cells were also recently found to arise from a…

Continue ReadingCombinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells

RNA Analysis by Biosynthetic Tagging (RABT): a tool for the identification of cell type-specific RNAs

  • Post author:
  • Post published:July 13, 2025
  • Post category:

Advancing our understanding of stem cell biology often relies on answers to the following types of questions: What are the differences in gene expression between a stem cell and the…

Continue ReadingRNA Analysis by Biosynthetic Tagging (RABT): a tool for the identification of cell type-specific RNAs

Derivation and Characterization of Myeloproliferative Disorder Stem Cells from Human ES Cells

  • Post author:
  • Post published:July 13, 2025
  • Post category:

Cancer is the leading cause of death for people younger than 85. High cancer mortality rates related to resistance to therapy and malignant progression underscore the need for more sensitive…

Continue ReadingDerivation and Characterization of Myeloproliferative Disorder Stem Cells from Human ES Cells
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us